Skip to content

Acquired Amyloid Peripheral Neuropathy C5680847

Published: July 22, 2026Updated: August 20, 2026

Nerve damage caused by abnormal protein deposits that accumulate in peripheral nerves. It typically affects older adults and can cause weakness, numbness, and pain. Treatment aims to stop the underlying protein production.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Paresthesia (numbness/tingling in extremities)

(neurologic)

Progressive muscle weakness

(neurologic)

Autonomic dysfunction (orthostatic hypotension, GI symptoms)

(neurologic)

Sensory ataxia

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Treatment of Underlying Plasma Cell Dyscrasia

Chemotherapy or targeted therapies directed at the underlying plasma cell disorder (such as multiple myeloma or monoclonal gammopathy) to reduce amyloid production.

medication

Additional treatment options

Neuropathic Pain Management

Use of gabapentinoids, tricyclic antidepressants, or SNRIs to manage neuropathic pain symptoms associated with amyloid neuropathy.

medication

Physical Therapy and Rehabilitation

Customized exercise programs, gait training, and balance exercises to maintain function and prevent falls in patients with peripheral neuropathy.

physical_therapy

Tafamidis or Patisiran

Disease-modifying agents that may stabilize transthyretin or reduce its production in transthyretin amyloidosis to slow disease progression.

medication

Foot Care and Assistive Devices

Proper footwear, regular foot inspections, and use of assistive devices such as canes or walkers to prevent injuries and maintain mobility.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Acquired Amyloid Peripheral Neuropathy C5680847?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Merlini G, Dispenzieri A. Myloid peripheral neuropathy: clinical manifestations and diagnostic approach. Neurology. 2022.

review2022
2

Gertz MA, Kyle RA. Amyloidosis: revised diagnostic criteria and treatment guidelines. Blood Adv. 2021.

guideline2021
3

Sanchorawala V, Skinner M. Bortezomib in AL amyloidosis with peripheral neuropathy. J Clin Oncol. 2020.

clinical_trial2020
4

Rajkumar SV, Dimopoulos MA. Autologous stem cell transplantation in systemic amyloidosis: a meta-analysis. Haematologica. 2019.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Acquired Amyloid Peripheral Neuropathy C5680847. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy